Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells
Cancer Genomics - Proteomics · 2024
DOI: 10.21873/cgp.20426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2024. Verfasst von Masato Yoshizawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan; kd20011@ms.kyoto-phu.ac.jp. Hauptthemen laut MEDLINE: Matrix Attachment Region Binding Proteins, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Pancreatic cancer is one of the most lethal malignant cancers worldwide and the seventh most common cause of cancer-related death in both sexes. Herein, we analyzed open access data and discovered that expression of a gene called deoxynucleotidyltransferase terminal-interacting protein 2 (DNTTIP2) is linked to prognosis of pancreatic ductal adenocarcinoma (PDAC). We then elucidated the role of DNTTIP2 in the proliferation of pancreatic cancer cells in vitro. MATERIALS AND METHODS: A WST-8 assay, cell cycle analysis, Annexin-V staining, quantitative reverse transcription-PCR, and western blot analysis were conducted to assess cell proliferation, cell cycle, apoptosis, and expression of DNTTIP2 mRNA and protein, respectively, in DNTTIP2-depleteted MIA-PaCa-2 and PK-1 cells. RESULTS: Depletion of DNTTIP2 induced G1 arrest in MIA-PaCa-2 cells by decreasing expression of special AT-rich sequence binding protein 1 (SATB1) and cyclin-dependent kinase 6 (CDK6). In addition, depletion of DNTTIP2 induced G2 arrest in PK-1 cells by decreasing expression of CDK1. Depletion of DNTTIP2 did not induce apoptosis in MIA-PaCa-2 or PK-1 cells. CONCLUSION: DNTTIP2 is involved in proliferation of pancreatic cancer cells. Thus, DNTTIP2 is a potential target for inhibiting progression of pancreatic cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan; kd20011@ms.kyoto-phu.ac.jp.
- Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan; ash@mb.kyoto-phu.ac.jp.
Zitieren
APA
Yoshizawa, M., Shiozaki, A., & Ashihara, E. (2024). Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20426
Vancouver
Yoshizawa M, Shiozaki A, Ashihara E. Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells. Cancer Genomics - Proteomics. 2024. doi:10.21873/cgp.20426
BibTeX
@article{Yoshizawa2024,
author = {Yoshizawa, Masato and Shiozaki, Atsushi and Ashihara, Eishi},
title = {Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells},
journal = {Cancer Genomics - Proteomics},
year = {2024},
doi = {10.21873/cgp.20426}
}
EUVIMED